NCT00484016

Brief Summary

There are limited numbers of retrospective studies showing the effectiveness of adjuvant chemotherapy over observation in resected lung cancers.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2006

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2006

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 8, 2007

Completed
Last Updated

August 13, 2013

Status Verified

August 1, 2013

Enrollment Period

1.2 years

First QC Date

June 4, 2007

Last Update Submit

August 9, 2013

Conditions

AdjuvantChemotherapyLungCancers

Keywords

adjuvantchemotherapyobservationresectedcancers

Eligibility Criteria

Age18 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients that received adjuvant chemotherapy
  • years

You may not qualify if:

  • Any patients that have not received adjuvant chemotherapy
  • Patients under 18 or over 88

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J; International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004 Jan 22;350(4):351-60. doi: 10.1056/NEJMoa031644.

    PMID: 14736927RESULT

Related Links

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Ramaswamy Govindan, M.D.

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2007

First Posted

June 8, 2007

Study Start

February 1, 2006

Primary Completion

April 1, 2007

Study Completion

April 1, 2007

Last Updated

August 13, 2013

Record last verified: 2013-08